Keudell/Morrison Wealth Management’s Checkpoint Therapeutics CKPT Stock Holding History

Keudell/Morrison Wealth Management’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,000	Closed	-$40.4K	–	232
2025 Q1	$40.4K	Buy	+10,000	New	+$33.3K	0.01%	217

Keudell/Morrison Wealth Management's CKPT Position: Q2 2025 in Review

Keudell/Morrison Wealth Management sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 10,000 shares — an estimated $40.4K sold.

Keudell/Morrison Wealth Management first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $40.4K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Keudell/Morrison Wealth Management reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Keudell/Morrison Wealth Management sold 10,000 Checkpoint Therapeutics shares in Q2 2025, an estimated $40.4K.
Keudell/Morrison Wealth Management first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
Keudell/Morrison Wealth Management's Checkpoint Therapeutics position peaked at $40.4K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Keudell/Morrison Wealth Management's 13F filing for Q2 2025, filed 22 Jul 2025.